ARCHIVES

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

FDA Designates Zometa For Priority Review.

November 30, 2001

“The President Has Cancer”: NCI Surgery Chief Breaks The News To Reagans And The World as Chief Spokesman After Surgery

July 19, 1985